News & Publications

NEWS & PUBLICATIONS

Learn more about Prous Institute and our progress in drug discovery, technology, industry partnerships, collaborations and scientific articles.


Prous Institute has been invited to speak at the Chem-Bio Informatics Society (CBI) Annual Meeting "iPS cells, Ion channels, in silico Technologies: Leading to a New Drug Discovery Paradigm" which takes place in Tokyo, Oct. 28-30, 2014. During the CBI session "in silico approaches for drug targets" Oct. 29 (Wed) 14:00-15:30, Josep Prous, Jr., Ph.D., Vice President Research and Development, will p...


Prous Institute for Biomedical Research, a sponsor of Informa's 7th Annual Genotoxic Impurities Conference to be held in Berlin, June 24-25, 2014, will present the SYMMETRY, the world’s first integrated in silico solution for drug discovery and safety screening. The platform features models for a wide range of efficacy and toxicology endpoints, including bacterial mutagenicity to support the...


At the 16th International Workshop on Quantitative Structure-Activity Relationships in Environmental and Health Sciences in Milan (QSAR 2014) Prous Institute will present a poster on SYMMETRY's Global Mechanism of Action (MoA) model and an interesting application of the model to predict the relevant mechanisms of action associated with a binary data set for a given endpoint. A case study is descri...


Prous Institute for Biomedical Research, a sponsor of the GTA ANNUAL MEETING to be held in Newark, Delaware, May 7-8, 2014, will introduce SYMMETRY, the world’s first integrated in silico solution for drug discovery and safety screening.  The platform integrates models for a wide range of efficacy, toxicology and human adverse events endpoints. Prous Institute will present a poster on t...


Prous Institute for Biomedical Research will participate in the 53rd ANNUAL SOT MEETING to be held in Phoenix, Mar 24-27, 2014.  Prous Institute Symmetry®, the world’s first integrated in silico solution for drug discovery and safety screening, supports decisions in the design and optimization of drug candidates and helps minimize potential liabilities in the earliest stages of drug...

Page 4 of 7First   Previous   1  2  3  [4]  5  6  7  Next   Last